Award

Purchase Order #75N98026P01509

Purchase of Cryopreserved HepaRG Cells for Toxicology Research

Buyer

National Institutes of Health

Award Amount

$23,850.00

Ceiling

$23,850.00

Awarded

September 02, 2026

Period of Performance

Sep 02, 2026 – Sep 01, 2027

Identifier

75N98026P01509

NAICS

325414

This award represents a purchase order contract made by the National Institute of Environmental Health Sciences (NIEHS), specifically within its Division of Translational Toxicology and Mechanistic Toxicology Branch. The recipient, Life Technologies Corporation, is a well-known biotechnology company specializing in providing biological products and reagents for scientific research. Under this contract, Life Technologies Corporation will supply 30 vials of cryopreserved HepaRG cells, which are essential for conducting advanced toxicological studies. These human liver cells are valuable for assessing chemical toxicity and understanding mechanisms of toxic effects, thus supporting the agency's health and safety mission. The contract covers delivery and provision of these specialized cells, ensuring their quality and usability for laboratory research. This purchase order was awarded through a competitive process to secure specialized biological research materials and carries a timeline spanning approximately one year. The contract supports ongoing efforts in environmental health research and toxicology, contributing to public health advancements.

Description

THE PURPOSE OF THIS PURCHASE ORDER IS TO PROVIDE THE NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES (NIEHS) / DIVISION OF TRANSLATIONAL TOXICOLOGY (DTT) / THE MECHANISTIC TOXICOLOGY BRANCH (MMB) WITH 30 VIALS OF CRYOPRESERVED HEPARG CELLS. PLEAS

View original record